טוען...
Pathology assessment is necessary to validate translational endpoints in preclinical aging studies
The Geropathology Research Network has established a plan to identify and use pathology-based surrogate endpoints for aging intervention in preclinical drug studies to provide a predictable and short-term anti-aging drug response in line with clinical trials. The plan involves pathological assessmen...
שמור ב:
| הוצא לאור ב: | Pathobiol Aging Age Relat Dis |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Co-Action Publishing
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808080/ https://ncbi.nlm.nih.gov/pubmed/27015829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/pba.v6.31478 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|